Raising the quality of cost-utility analyses: Lessons learnt and still to learn

Health Policy

Volumn 46, Issue 3, 1999, Pages 217-238

  Gerard, Karen ^a   Smoker, Irenie ^b   Seymour, Janelle ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b New South Wales Government   (Australia)

Author keywords

Cost utility analysis; Economic evaluation; Resource allocation; Review of cost utility analyses

Indexed keywords

ARTICLE; COST UTILITY ANALYSIS; ECONOMIC ASPECT; NONHUMAN; PEER REVIEW; RESOURCE ALLOCATION;

EID: 0032966805     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(98)00061-X     Document Type: Article

References (37)

1. Alban A. Economic appraisal: what is the use? Revisited. Proceedings of the Eighth Nordic Health Economists' Study Group Meeting, Turku, Finland. 1987.
2. Alban A. The role of economic appraisal in Denmark. Social Science and Medicine. 38:1994;1647-1652.
3. Ross J. The use of economic evaluation in health care: Australian decision makers' perspective. Health Policy. 31:1995;103-110.
4. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee including major submissions involving economics analyses. 1992;Australian Government Publishing Service, Canberra.
5. Iko P. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada. 1st ed:1994;CCOHTA Publications, Ottawa.
6. Drummond M.F., Cooke J., Walley T. Economic evaluation in health care decision making: evidence from the UK. 1996;University of York, York. Discussion paper 148.
7. Jönsson B. Economic evaluation of medical technologies in Sweden. Social Science and Medicine. 45:1997;597-604.
8. Rutten E.E. Economic evaluation in support of national health policy: the case of The Netherlands. Social Science and Medicine. 45:1997;605-620.
9. Medical Services Advisory Committee. Australia first in world to adopt evidence-based medicine - www.health.gov.au/mediarel/mw7798.htm, 6 April 1998.
10. Lee J.T., Sanchez L.A. Interpretation of cost-effective and soundness of economic evaluations in the pharmacy literature. Australian Journal of Health Promotion. 48:1991;2622-2627.
11. Udvarhelyi S., Colditz G.A., Rai A., Epstein A.M. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Annals of Internal Medicine. 116:1992;238-244.
12. Adams M.E., McCall N., Gray S.M., Orza M.J., Chalmers T.C. Economic analysis in randomised control trials. Medical Care. 30:1992;231-233.
13. Gerard K. Cost-utility in practice: a policy maker's guide to the state of the art. Health Policy. 21:1992;249-280.
14. Nord E. Towards quality assurance in QALY calculations. International Journal of Technology Assessment in Health Care. 9:1993;37-45.
15. Salkeld G., Davey P., Arnolda G. A critical review of health-related economic evaluations in Australia: implications for health policy. Health Policy. 31:1995;111-125.
16. Mason J., Drummond M. Reporting guidelines for economic studies. Health Economics. 4:1995;85-94.
17. Neumann P.J., Zinner D.E., Wrigh J.C. Are methods for estimating QALYs in cost-effectiveness analysis improving? Medical Decision Making. 17:1997;402-408.
18. Baladi J.F., Menon D., Otten N. Use of economic evaluation guidelines: 2 years experience in Canada. Health Economics. 7:1998;221-227.
19. Seigel J.E., Weinstein M.C., Russell L.B., Gold M.R. Recommendation for reporting cost-effectiveness analysis. Journal of the American Medical Association. 276:1996;1339-1341.
20. Drummond M.F., Richardson S., O'Brien B., Levine M., Heyland D. Users' guides to the medical literature: how to use an article on economic analysis of clinical practice-A. Are the results of the study valid? Journal of the American Medical Association. 277:1997;1552-1557.
21. O'Brien B., Heyland D., Richardson S., Levine M., Drummond M.F. Users' guides to the medical literature: how to use an article on economic analysis of clinical practice-B. What are the results and will they help me in caring for my patients? Journal of the American Medical Association. 277:1997;1802-1806.
22. Hutton J. Economic evaluation of healthcare: a halfway technology. Health Economics. 3:1994;1-4.
23. Drummond M., Brandt A., Luce B., Rovira J. Standardizing methodologies for economic evaluation in health care. International Journal of Technology Assessment in Health Care. 9:1993;26-36.
24. Economic analysis of health care technology. A report on principles. Annals of Internal Medicine. 123:1995;61-70.
25. Evans R. Manufacturing consensus, marketing truth: guidelines for economic evaluations. Annals of Internal Medicine. 123(1):1995;59-60.
26. Rovira J. Standardization of the economic evaluation of health technologies. European developments. Medical Care. 34(Suppl 12):1996;182-188.
27. Harris A., Crowley S., Defina J., Hawthorn G. Checklist for the design protocol to collect economic data alongside clinical trials in Australia. 1996;Centre for Health Program Evaluation, Monash University, Melbourne. Working Paper 51.
28. Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd ed:1997;CCOHTA Publications, Ottawa.
29. Drummond M.F., Jefferson T.O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal. 313:1996;275-283.
30. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York.
31. Health economic evaluations database (HEED). 1996;OHE-IFPMA Database, 1995-1997, London.
32. Guidelines for the conduct of reviews of the research literature. 1994;York NHS Centre for Reviews and Dissemination, University of York, York. CRD report 4.
33. Jefferson T., Smith R., Yeo Y. et al. Evaluating the BMJ guidelines for economic submissions. Journal of the American Medical Association. 280:1998;275-277.
34. Drummond M.F., Stoddart G.L., Torrance G.W. Principles of economic evaluation in health care. 1987;Oxford University Press, Oxford.
35. Gerard K., Mooney G. QALY league tables: handle with care. Health Economics. 2:1993;59-64.
36. Guidance for purchasers: improving outcomes in breast cancer-the research evidence. 1996;Department of Health, London. Catalogue no. 96CC0022.
37. Russell L.B., Gob M.R., Seigel J.E., Daniels N., Weinstein M.C. The role of cost-effectiveness analysis in health and medicine. Journal of the American Medical Association. 276:1996;1172-1177.